Phase II study of preoperative intensity modulated radiotherapy with gemcitabine and S-1 in patients with locally advanced pancreas cancer
Not Applicable
- Conditions
- Pancreas cancer
- Registration Number
- JPRN-UMIN000008614
- Lead Sponsor
- 3rd department of surgery Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients have four months or less life expectancy. 2) Patients have severe co-morbidities disease. 3) Woman of child bearing potential, expectant or nursing woman. 4) Patients have a history of severe drug allergy. 5) Patients have synchronous active cancer. 6) Patients had distant metastases after induction chemotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Resection rate Tumor response rate Local recurrence rate Progression free survival Adverse event rate QO